Award Year / Program / Phase:2009 / SBIR / Phase I
Agency:HHS
Principal Investigator:Terry Tandeski
Award Amount:$131,371.00
Abstract:
DESCRIPTION (provided by applicant): The realization of the remarkable potential of human embryonic stem cells or induced pluripotent stem cells to treat human disease cannot occur unless new animal-free methods for the expansion of undifferentiated stem c
ells are developed. An optimal… More
Award Year / Program / Phase:2010 / SBIR / Phase I
Agency:HHS
Principal Investigator:Sarah Atzet
Award Amount:$106,851.00
Abstract:
DESCRIPTION (provided by applicant): An unmet need for expansion of primary cells and progenitor cells in three dimensions (3-D) is an extracellular matrix (ECM) substitute with user-controllable composition and compliance to which ECM proteins or syntheti
c peptides can be covalently attached by… More